Jazz Pharmaceuticals plc (J7Z) — Financial Flexibility Index
Jazz Pharmaceuticals plc (J7Z) has a Financial Flexibility Index of 0.06x as of March 2026. Free cash flow of €427.90 Million (operating CF €408.20 Million minus capex €19.70 Million) represents 0% of total liabilities (€7.33 Billion). Check Jazz Pharmaceuticals plc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jazz Pharmaceuticals plc Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for Jazz Pharmaceuticals plc across 13 annual periods. For the full cash flow conversion analysis, see how efficiently does Jazz Pharmaceuticals plc generate cash.
Annual Financial Flexibility Index for Jazz Pharmaceuticals plc (2013–2025)
Year-by-year free cash flow to debt coverage for Jazz Pharmaceuticals plc. Explore Jazz Pharmaceuticals plc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.21x | €1.57 Billion | €1.36 Billion | €7.34 Billion | ▲ +17.0% |
| 2024 | 0.18x | €1.44 Billion | €1.40 Billion | €7.92 Billion | ▲ +23.0% |
| 2023 | 0.15x | €1.13 Billion | €1.09 Billion | €7.66 Billion | ▼ -11.7% |
| 2022 | 0.17x | €1.30 Billion | €1.27 Billion | €7.75 Billion | ▲ +73.5% |
| 2021 | 0.10x | €806.15 Million | €778.51 Million | €8.33 Billion | ▼ -69.6% |
| 2020 | 0.32x | €914.65 Million | €899.65 Million | €2.88 Billion | ▼ -5.4% |
| 2019 | 0.34x | €816.54 Million | €776.40 Million | €2.43 Billion | ▲ +0.4% |
| 2018 | 0.33x | €819.27 Million | €798.90 Million | €2.45 Billion | ▲ +11.8% |
| 2017 | 0.30x | €722.04 Million | €693.09 Million | €2.41 Billion | ▲ +13.1% |
| 2016 | 0.26x | €773.97 Million | €592.39 Million | €2.92 Billion | ▼ -19.1% |
| 2015 | 0.33x | €567.90 Million | €531.94 Million | €1.73 Billion | ▲ +45.2% |
| 2014 | 0.23x | €443.95 Million | €407.61 Million | €1.97 Billion | ▼ -28.7% |
| 2013 | 0.32x | €298.41 Million | €288.43 Million | €942.69 Million | — |